Evidence map›Paper›PMID 25587105›Full record

ArticleClinical journal of the American Society of Nephrology : CJASN2015

Provider visit frequency and vascular access interventions in hemodialysis.

Kevin F Erickson, Matthew W Mell, Wolfgang C Winkelmayer, Glenn M Chertow, Jay Bhattacharya

Open access · bronzeAbstract read
In one paragraph

Article in Clinical journal of the American Society of Nephrology : CJASN, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Evaluating the Evidence behind Policy Mandates in US Dialysis Care.Journal of the American Society of Nephrology : JASN · 2018
    Article
  5. Article
  6. Alternative strategies needed to improve vascular access outcomes.Clinical journal of the American Society of Nephrology : CJASN · 2015
    Article
  7. Patient Satisfaction Is Associated With Dialysis Facility Quality and Star Ratings.American journal of medical quality : the official journal of the American College of Medical Quality
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Kevin F EricksonDivision of Nephrology, Department of Medicine, Center for Primary Care and Outcomes Research, Department of Medicine, and kevine1@stanford.edu.
Matthew W MellDivision of Vascular Surgery, Department of Surgery, Stanford University School of Medicine, Palo Alto, California; and.
Wolfgang C WinkelmayerSection of Nephrology, Baylor College of Medicine, Houston, Texas.
Glenn M ChertowDivision of Nephrology, Department of Medicine.
Jay BhattacharyaCenter for Primary Care and Outcomes Research, Department of Medicine, and.
Center for Outcomes Research and Clinical Epidemiology · ITBaylor College of Medicine · USStanford University · US

Funding

CORE--PROGRAM DEVELOPMENTP30AG017253 · NIA · STANFORD UNIVERSITY · PI BHATTACHARYA, JAY · 1999 to 2019
$5.8M
TRAINING PROGRAM IN ACADEMIC NEPHROLOGYT32DK007357 · NIDDK · STANFORD UNIVERSITY · PI CHERTOW, GLENN MATTHEW · 1986 to 2022
$4.8M
Estimating the Potential Medicare Savings from Comparative Effectiveness ResearchR37AG036791 · NIA · STANFORD UNIVERSITY · PI GARBER, ALAN MICHAEL · 2011 to 2016
$2.4M
Mentoring Patient-Oriented Clinical Investigators in NephrologyK24DK085446 · NIDDK · STANFORD UNIVERSITY · PI CHERTOW, GLENN MATTHEW · 2010 to 2022
$1.4M
"G-code" Reimbursement and Outcomes in HemodialysisF32HS019178 · AHRQ · STANFORD UNIVERSITY · PI ERICKSON, KEVIN · 2010 to 2012
$201k
AHRQ HHS F32 HS019178AHRQ HHS F32-HS019178NIA NIH HHS P30 AG017253NIA NIH HHS R37 AG036791NIA NIH HHS R37-AG036791NIDDK NIH HHS K24 DK085446NIDDK NIH HHS K24-DK085446NIDDK NIH HHS T32 DK007357NIDDK NIH HHS T32-DK007357
6 · The paper itself

Abstract

BACKGROUND AND

objectivesMedicare reimbursement policy encourages frequent provider visits to patients with ESRD undergoing hemodialysis. This study sought to determine whether more frequent face-to-face provider (physician and advanced practitioner) visits lead to more procedures and therapeutic interventions aimed at preserving arteriovenous fistulas and grafts, improved vascular access outcomes, and fewer related hospitalizations. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Multivariable regression was used to evaluate the association between provider (physician and advanced practitioner) visit frequency and interventions aimed at preserving vascular access, vascular access survival, hospitalization for vascular access infection, and outpatient antibiotic use in a cohort of 63,488 Medicare beneficiaries receiving hemodialysis in the United States. Medicare claims were used to identify the type of vascular access used, access-related events, and vascular access failure.

resultsOne additional provider (physician and advanced practitioner) visit per month was associated with a 13% higher odds of receiving an intervention to preserve vascular access (95% confidence interval [95% CI], 12% to 14%) but was not associated with vascular access survival (hazard ratio, 1.01; 95% CI, 0.99 to 1.03). One additional provider visit was associated with a 9% (95% CI, 5% to 14%) lower odds of hospitalization for vascular access infection and a corresponding 9% (95% CI, 5% to 14%) higher odds of outpatient intravenous antibiotic administration. However, the associated changes in absolute probabilities of hospitalization and antibiotic administration were small.

conclusionsMore frequent face-to-face provider (physician and advanced practitioner) visits were associated with more procedures and therapeutic interventions aimed at preserving vascular accesses, but not with prolonged vascular access survival and only a small decrease in hospitalization for vascular access.

Indexed as

Process Assessment, Health CareAdministration, IntravenousAgedAmbulatory CareAnti-Bacterial AgentsArteriovenous Shunt, SurgicalBlood Vessel ProsthesisBlood Vessel Prosthesis ImplantationFemaleHealth ResourcesHospitalizationHumansKidney Failure, ChronicMaleMedicareMultivariate AnalysisAnti-Bacterial Agentsand outcomesarteriovenous fistulaarteriovenous graftchronic hemodialysiseconomic analysisepidemiology

Identifiers

PMID25587105
PMCPMC4317740
OpenAlexW2100584709

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.